Theory Paper IDrNB Cardiology – Theory Notes
INDICATIONS OF CARDIAC CATHETERIZATION IN CCHD
ITHE PARADIGM SHIFT (THE MULTIMODALITY IMAGING ERA)
- Evolution from Diagnostic to Therapeutic: With the high diagnostic accuracy of Transthoracic/Transesophageal Echocardiography (TTE/TEE), Multidetector CT Angiography (MDCTA), and Cardiac MRI (CMR) for defining intracardiac and extracardiac anatomy, routine purely anatomical diagnostic catheterization in Cyanotic Congenital Heart Disease (CCHD) has largely been replaced.
- Current Role of Catheterization: Invasive cardiac catheterization in CCHD is now performed for two specific mandates: (1) Invasive Hemodynamic Assessment (measuring pressures, transpulmonary gradients, and Pulmonary Vascular Resistance [PVR] that non-invasive imaging cannot directly measure, or performing selective angiography of complex collateral beds), and (2) Transcatheter Palliative or Definitive Interventions.
IIDIAGNOSTIC INDICATIONS (HEMODYNAMICS AND SELECTIVE ANATOMY)
- Assessment of Pulmonary Vascular Resistance (PVR) and Operability (Class I): The single most critical diagnostic indication in CCHD patients with unrestricted pulmonary blood flow (e.g., Truncus Arteriosus, d-TGA with VSD, unoperated Single Ventricle, or DORV without PS) presenting beyond infancy. Direct Fick or thermodilution measurement of PVR and Qp:Qs determines whether the patient is operable (PVR less than 3 Wood Units [Class I] or 3 to less than 5 Wood Units [Class IIa] in ESC 2020 ACHD guidelines; indexed PVR less than 4 to 6 Wood Units·m2 in pediatric guidelines) versus inoperable Eisenmenger physiology.
- Acute Vasoreactivity Testing: In pediatric patients with borderline elevated PVR (4 to 8 Wood Units·m2), acute vasodilator challenge using inhaled Nitric Oxide (iNO at 20 to 40 ppm) and/or 100 percent Oxygen assesses pulmonary vascular reactivity (a drop in PVR index by greater than 20 percent to a final PVRi below 6 WU·m2 with a fall in the PVR/SVR ratio below 0.3 favors operability, often with a fenestrated patch). (Note: When high oxygen concentration is inhaled, dissolved plasma oxygen must be included in the Fick equation to avoid erroneous PVR calculation.)
- Selective Mapping and Pressure Measurement in MAPCAs (TOF with Pulmonary Atresia): While CT Angiography maps the 3D origins of Major Aortopulmonary Collateral Arteries (MAPCAs), cardiac catheterization remains essential to (1) measure the distal segmental pressure within each individual MAPCA (identifying lung segments protected by proximal stenosis vs. those with segmental pulmonary hypertension), and (2) perform selective MAPCA and pulmonary vein wedge angiography to differentiate dual-supply (communicating) from sole-supply (essential) lung segments prior to unifocalization.
- Pre-Glenn and Pre-Fontan Single-Ventricle Hemodynamic Staging: Mandatory prior to Bidirectional Glenn or Fontan completion to confirm mean PA pressure less than 15 mmHg, PVR less than 2 to 3 Wood Units, transpulmonary gradient less than 5 to 6 mmHg, systemic ventricular end-diastolic pressure (VEDP) less than 12 mmHg, confluent pulmonary arteries (Nakata Index and McGoon Ratio), and to identify aortopulmonary or venovenous collaterals.
- Coronary Artery Assessment in PA-IVS: In neonates with Pulmonary Atresia with Intact Ventricular Septum (PA-IVS) and a diminutive, hypertensive right ventricle, right ventricular angiography and selective coronary angiography are mandatory to identify Right Ventricle-Dependent Coronary Circulation (RVDCC) (ventriculocoronary fistulae/sinusoids with proximal coronary artery stenoses/interruptions); if RVDCC is present, decompressing the RV causes fatal myocardial infarction, mandating a single-ventricle pathway or transplant.
| CCHD Clinical Scenario | Primary Catheterization Objective | Key Hemodynamic / Angiographic Target |
|---|---|---|
| Late-Presenting CCHD with High Pulmonary Flow (d-TGA+VSD, Truncus, Single Ventricle) | Assess PVR, Qp:Qs, and Operability (+/- iNO + O2 vasoreactivity) | PVR <3 WU (Class I) or 3 to <5 WU (Class IIa) in adults; pediatric PVRi <4–6 WU·m2 and PVR/SVR <0.3 |
| TOF with Pulmonary Atresia & MAPCAs | Selective MAPCA angiography & distal pressures; PV wedge injections | Differentiate sole-supply (essential) vs. dual-supply segments; coil dual-supply collaterals |
| Pre-Glenn / Pre-Fontan Staging | Measure passive cavopulmonary hemodynamics and collateral burden | mPAP <15 mmHg, PVR <2–3 WU, VEDP <12 mmHg, Nakata Index >200 mm2/m2 |
| Pulmonary Atresia with Intact Septum (PA-IVS) | RV angiogram + aortogram/coronary angiogram | Rule out RV-Dependent Coronary Circulation (RVDCC) before attempting RV decompression |
IIITHERAPEUTIC AND INTERVENTIONAL INDICATIONS
- Balloon Atrial Septostomy (Rashkind Procedure — Class I): Emergency life-saving bedside or cath-lab procedure for neonates with d-Transposition of the Great Arteries (d-TGA) and a restrictive interatrial communication presenting with profound hypoxemia and metabolic acidosis (also indicated in Tricuspid Atresia, Pulmonary Atresia, or HLHS with a restrictive ASD). Enlarges the foramen ovale to allow bidirectional interatrial mixing and decompress the left atrium.
- Transcatheter Patent Ductus Arteriosus (PDA) Stenting: Frontline neonatal alternative to a surgical modified Blalock-Thomas-Taussig (mBTT) shunt in neonates with duct-dependent pulmonary blood flow (e.g., Pulmonary Atresia, Tricuspid Atresia, severe TOF), promoting symmetrical branch PA growth with lower procedural morbidity and shorter ICU stay.
- Right Ventricular Outflow Tract (RVOT) Stenting: Palliative transcatheter bridge to complete surgical repair in high-risk, low-birth-weight, or severely cyanotic infants with Tetralogy of Fallot and refractory hypercyanotic spells or hypoplastic branch pulmonary arteries.
- Balloon Pulmonary Valvuloplasty (BPV) and Radiofrequency Valve Perforation: Definitive emergency therapy for neonates with Critical Valvular Pulmonary Stenosis (duct-dependent right-to-left atrial shunt), or radiofrequency wire perforation followed by BPV in membranous PA-IVS with an adequate tripartite RV and no RVDCC.
- Transcatheter Embolization of Vascular Collaterals: Coil or vascular plug occlusion of dual-supply MAPCAs (to eliminate left heart volume overload before bypass), acquired aortopulmonary collaterals in Glenn/Fontan circuits, or venovenous collaterals and pulmonary arteriovenous malformations (PAVMs) causing progressive cyanosis.
- Conduit, Branch PA, and Fontan Fenestration Interventions: Balloon angioplasty and stenting of stenotic RV-to-PA conduits or branch pulmonary arteries, Transcatheter Pulmonary Valve Replacement (TPVR), and percutaneous creation, stenting, or device closure of a Fontan fenestration.
IVPRACTICAL CONSIDERATIONS IN THE INDIAN CLINICAL CONTEXT
- High Volume of Late-Presenting Operability Studies: Because many Indian children with CCHD and increased pulmonary blood flow or large MAPCAs present in late childhood or adolescence, invasive PVR operability assessment and selective collateral catheterization remain everyday procedures in Indian tertiary centers.
- Transcatheter Palliation in Malnourished Infants (RVOT and PDA Stenting): Indian infants with severe TOF or duct-dependent CCHD frequently present with severe protein-energy malnutrition, low weight (under 3 to 4 kg), or active respiratory infection where neonatal cardiopulmonary bypass carries high mortality; RVOT stenting or PDA stenting serves as a cost-effective, life-saving bridge allowing somatic growth and pulmonary artery rehabilitation over 4 to 6 months before definitive surgical repair.
- Stabilization for Transport (Rashkind Septostomy): In neonates with d-TGA born outside major cardiac surgical hubs, urgent Echo-guided or fluoroscopic Rashkind Balloon Atrial Septostomy stabilizes arterial oxygenation, allowing weaning from costly Prostaglandin E1 (Alprostadil) infusions and safe transport to a surgical center.
Key references
- Baumgartner H, De Backer J, Babu-Narayan SV, et al.: 2020 ESC Guidelines for the management of adult congenital heart disease, European Heart Journal, 2020.
- Feltes TF, Bacha E, Beekman RH III, et al.: Indications for Cardiac Catheterization and Intervention in Pediatric Cardiac Disease: A Scientific Statement From the American Heart Association, Circulation, 2011.
- Glatz AC, Petit CJ, Goldstein BH, et al.: Comparison Between Patent Ductus Arteriosus Stent and Modified Blalock-Taussig Shunt as Palliation for Infants With Ductal-Dependent Pulmonary Blood Flow, Circulation, 2018.
meritmedscript.comDr. Sidhartha Mullapudi
